… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 69 of 2459…h (2 RCTs ; SMD 0.30, 95% CI 0.04–0.57; p=0.0256). In contrast, propranolol monotherapy was associated with shorter time to death (SMD −0.8…
…ey PK and PD parameters, as well as a similar safety profile to salbutamol with HFA-134a, supporting salbutamol MDI with HFA-152a as a the…
… AD drug prescription: valacyclovir HR 0.10, acyclovir HR 0.09, famciclovir HR 0.07. The incidence rate of AD treatment initiation was subs…
…/864/77By 203617/8615/77*2 of these patients already prescribed Tirzepatide for poor diabetes control…
… include Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) or ivabradine and was restricted to HFrEF.We have here introduced the Blackpo…
…nthrene (Phe) is a common air pollutant that is associated with cardiometabolic disease. Phe has previously been reported to alter adipokine release fr…
…, 65% of patients were male. Median LVEF was 50% [IQR 41 – 56]. β-blockers were prescribed in 88.8% of patients, ARNI in 78.1%, MRAs in 45…
…Abstract 368 Figure 2ROC curve of queen of hearts algorithm for STEMI diagnosis…
…auses including pulmonary embolism (PE), heart failure (HF) and acute coronary syndrome (ACS). Despite guideline recommendations for risk stratificatio…
…o (OR), Confidence Interval (CI), Left Ventricle (LV), New York Heart Failure Association (NYHA)…
…ivation profile relying on the activation of JAK/STAT pathways. Tofacitinib, a pan-JAK inhibitor, down regulates interferon (IFN) in human …